Cerezyme (imiglucerase) is a form of enzyme replacement therapy (ERT) used to treat Type 1 Gaucher disease in adults and children 2 years of age or older. It's given as an intravenous (IV) infusion by a healthcare provider. Overall, Cerezyme (imiglucerase) is well tolerated, but it can cause allergic or infusion-related reactions like hives or difficulty breathing.
Type 1 Gaucher disease in adults and children 2 years of age or older
Cerezyme (imiglucerase) is a modified (lab-made) version of the enzyme glucocerebrosidase that is normally found in the body. People with Gaucher disease don't have enough of this enzyme, which breaks down a fatty substance called glucosylceramide (also known as glucocerebroside or GL-1). As a result, there are higher levels of glucosylceramide in the body, and it can build up in the spleen, liver, and bones. Cerezyme (imiglucerase) works as an enzyme replacement for glucocerebrosidase and helps your body break down glucosylceramide.
Source: DailyMed
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Less common
Abdominal discomfort
decrease in blood pressure, decrease in frequency of urination
dizziness
headache
rash
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Can be used long-term, for at least 20 years, to treat Type 1 Gaucher disease
Can be used in children as young as 2 years of age
Safe to use if pregnant or breastfeeding
Fewer side effects compared to oral medications for Gaucher disease type 1
Might require frequent trips to the infusion center to receive treatment
Takes 1 to 2 hours to receive each infusion
Potential for allergic or infusion reactions with long-term use
Requires IV access, so it's not as convenient as taking a pill
It takes about 1 to 2 hours to give the full dose of Cerezyme (imiglucerase). Most commonly, you'll receive this medication at an infusion center or provider's office. In some cases, it can be given at home by a home health nurse.
You might experience an allergic or infusion-related reaction during or shortly after your Cerezyme (imiglucerase) infusion, some of which can be life-threatening. Let your provider know or get help right away if you experience any trouble breathing, hives, flushing, chest pain, skin turning blue, fast heartbeat, or dizziness.
You can feel some discomfort, pain, or burning at the IV infusion site when receiving Cerezyme (imiglucerase). Let your provider know if this is bothersome so it can be managed appropriately.
Cerezyme (imiglucerase) infusions can be shifted around travel or other plans, but it's best to stay on your regular schedule so you'll get the most benefit. If you miss an infusion, talk with your provider about rescheduling your appointment.
Talk to your provider about enrolling in a database for people with Gaucher disease. This database monitors Gaucher disease symptoms over time and the long-term effects of Cerezyme (imiglucerase).
Cerezyme (imiglucerase) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Risk factors: Having antibodies to Cerezyme (imiglucerase) after repeated treatments
Cerezyme (imiglucerase) can cause allergic or infusion-related reactions, which can be serious. These reactions can happen during or shortly after infusions. Your risk for reactions is higher with the more Cerezyme (imiglucerase) treatments you get. This is due to your body developing antibodies to Cerezyme (imiglucerase). Most people who develop antibodies do so within 6 to 12 months of starting treatment. Your provider might check your antibody levels occasionally during the first year of treatment.
Let your provider know right away if you experience any throat tightness, trouble breathing, cough, itching, hives, flushing, swelling, chest pain, skin turning blue, fast heartbeat, low blood pressure, dizziness, or fainting.
Cerezyme (imiglucerase) is an intravenous (IV) infusion that is administered by a healthcare provider. The dose depends on your weight and how severe your Type 1 Gaucher disease symptoms are. Your healthcare provider will determine the appropriate dose for you each time.
In general, the dose ranges from 2.5 units/kg three times a week to 60 units/kg once every two weeks.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
Type 1 Gaucher disease in adults and children 2 years of age or older
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.